Evidence map›Paper›PMID 42864442›Full record

ArticleEMBO molecular medicine2026

Extracellular RNA clearance by non-canonical cell-surface MDA5 protects against lung fibrosis.

Takashi Ishii, Masafumi Horie, Hirokazu Urushiyama, Yusuke Murakami, Tomoya Narita, Ryutaro Fukui, Kensuke Miyake, Akira Saito, Naomi Yamashita, Keiki Kumano and 1 more

Abstract read
In one paragraph

Article in EMBO molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Takashi IshiiDepartment of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. taishii-tky@umin.ac.jp.ORCID http://orcid.org/0000-0003-0662-0342
Masafumi HorieDivision of Molecular and Genomic Pathology, Department of Pathology, Graduate School of Medicine, Kobe University, Hyogo, Japan.
Hirokazu UrushiyamaDepartment of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Yusuke MurakamiDepartment of Pharmacotherapy, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo, Japan.
Tomoya NaritaDepartment of Pharmacotherapy, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo, Japan.
Ryutaro FukuiSynergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba, Japan.
Kensuke MiyakeSynergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba, Japan.
Akira SaitoDepartment of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Naomi YamashitaDepartment of Pharmacotherapy, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo, Japan.
Keiki KumanoDepartment of Pharmacotherapy, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo, Japan.
Hidenori KageDepartment of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Funding

grants-in-aid for scientific research (japan) 19K17668 and 22K16165
6 · The paper itself

Abstract

The role of innate immune receptors, specifically RNA sensors, in non-pathogen-driven lung fibrosis remains unclear. Here, we demonstrate that the cytosolic RNA sensor MDA5 could translocate to the cell surface upon bleomycin-induced damage. MDA5-deficient mice exhibited exacerbated lung fibrosis with increased IL-17A⁺ γδ T cells and neutrophils, which is independent of the canonical MAVS pathway and type I interferon signaling. Phenotypically, MDA5-deficient lung CD11b⁺ macrophages, which resemble human SPP1⁺ macrophages, showed elevated expression of CCR2 ligands. Mechanistically, cell-surface MDA5 acts as a scavenger receptor that captures extracellular self-RNA and shuttles it for lysosomal degradation. Loss of MDA5 leads to aberrant cellular RNA accumulation, triggering TLR8-dependent hyperproduction of CCR2 ligands. Analysis of human lung fibrosis samples from public datasets revealed SPP1⁺ macrophages are a major source of CCR2 ligands, suggesting their potential to activate monocytes. Our findings reveal an unrecognized protective function of MDA5 in lung fibrosis: preventing TLR8-mediated hyperinflammation through the lysosomal clearance of extracellular RNA. This mechanism provides crucial insights into the pathogenesis of fibrotic diseases like interstitial lung diseases.

Indexed as

DEAD-box RNA HelicasesPulmonary FibrosisRNAAnimalsBleomycinHumansInnate Immunity RecognitionInterferon-Induced Helicase, IFIH1MacrophagesMiceMice, Inbred C57BLMice, KnockoutReceptors, CCR2Toll-Like Receptor 8BleomycinDEAD-box RNA HelicasesIfih1 protein, mouseInterferon-Induced Helicase, IFIH1Receptors, CCR2RNAToll-Like Receptor 8

Identifiers

PMID42864442
PMCPMC13658825

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.